MTIM
AGN.PRA

Marathon Trading Investment Management’s Allergan plc AGN.PRA Stock Holding History

Marathon Trading Investment Management’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-828
Closed -$631K – 224
2016
Q4 		$631K Sell
828
-421
-34% -$318K 0.07% 78
2016
Q3 		$1.03M Hold
1,249
– – 0.14% 62
2016
Q2 		$1.04M Hold
1,249
– – 0.18% 63
2016
Q1 		$1.15M Hold
1,249
– – 0.22% 64
2015
Q4 		$1.29M Buy
1,249
+449
+56% +$451K 0.1% 115
2015
Q3 		$755K Buy
+800
New +$834K 0.04% 192

Other funds holding AGN.PRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Marathon Trading Investment Management's AGN.PRA Position: Q1 2017 in Review

Marathon Trading Investment Management sold out of Allergan plc (AGN.PRA) in Q1 2017, closing a stake of 828 shares — an estimated $631K sold.

Marathon Trading Investment Management first reported a position in AGN.PRA in Q3 2015 and held it in 6 quarters. The position peaked at $1.29M in Q4 2015. 106 funds tracked by Wall St. Rank hold AGN.PRA as of Q1 2017.

  • Marathon Trading Investment Management reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Marathon Trading Investment Management sold 828 Allergan plc shares in Q1 2017, an estimated $631K.
  • Marathon Trading Investment Management first reported a position in Allergan plc in Q3 2015 and held it in 6 quarters.
  • Marathon Trading Investment Management's Allergan plc position peaked at $1.29M in Q4 2015.
  • 106 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Marathon Trading Investment Management's 13F filing for Q1 2017, filed 12 May 2017.